Faculty Bibliography

IntroductionTraumatic intracranial aneurysms (TICAs) are rare, potentially fatal complications of traumatic brain injury (TBI) or iatrogenic insult. Often forming as pseudoaneurysms, TICAs result from direct arterial wall disruption. Their unique pathophysiology, delayed presentation, and high rupture risk pose diagnostic and therapeutic challenges. This review synthesizes current evidence on TICA pathogenesis, diagnosis, and treatment, with particular emphasis on the evolving role of angiographic diagnosis and endovascular intervention.MethodsA structured PubMed search was conducted, supplemented by manual citation screening. All study designs were considered with no date restrictions. Articles were included if they reported traumatic intracranial aneurysms in patients of any age and discussed diagnostic or therapeutic approaches. Data were synthesized thematically across epidemiology, pathophysiology, imaging, treatment (endovascular and surgical), and surveillance.ResultsTICAs typically arise at sites of direct injury or at fixed vessel segments (e.g., distal ACA, peripheral MCA, cavernous/supraclinoid ICA). Their delayed and subtle appearance necessitates high clinical suspicion and serial imaging. Digital subtraction angiography is the diagnostic gold standard, though immediate or early post-trauma studies may be negative. Endovascular techniques, particularly flow diversion, are increasingly favored for their minimally invasive nature and ability to achieve parent vessel reconstruction. Open surgery retains a role for lesions complicated by mass effect, intracerebral hematoma, or anatomy unsuitable for endovascular repair. Outcomes vary with aneurysm location, treatment timing, modality, and TBI severity.ConclusionTICAs represent a distinct, high-risk entity requiring timely diagnosis and individualized, multidisciplinary management. Endovascular approaches are increasingly favored. Further research is needed to guide optimal surveillance imaging protocols.

BACKGROUND AND OBJECTIVES/OBJECTIVE:Trans-sonolucent cranioplasty ultrasonography (TCUS) has been explored as a noninvasive tool for evaluating superficial temporal artery (STA)-middle cerebral artery (MCA) bypass patency. Previous research has focused on early postoperative feasibility. Data on its long-term utility and correlation with formal angiography remain scarce. We aimed to evaluate TCUS' role in postoperative STA-MCA bypass graft monitoring and its concordance with formal angiography. METHODS:This retrospective study included 46 consecutive direct STA-MCA anastomoses in 40 patients (March 2021-May 2024), all with sonolucent polymethyl methacrylate cranioplasty. Patient records were reviewed for demographics, disease and surgical characteristics, and outcomes. Postoperative TCUS was performed outpatient to monitor anastomotic patency. Formal follow-up angiography was also conducted, and radiographic data were reviewed for graft patency assessment and qualitative correlation with TCUS. RESULTS:Follow-up angiography was performed for 41 of 46 anastomoses (digital subtraction angiography, n = 34; computed tomography angiography, n = 4; magnetic resonance angiography, n = 3) at a median of 1.1 years, demonstrating 97.6% patency (40/41). Outpatient TCUS was performed in 32 of 46 bypasses (69.6%) with 100% patency at first scan (median 28.5 days). A second TCUS (n = 19, 41.3%) at a median of 8.4 months (3.9-13.6 months) showed robust flow in 94.7% of cases. One bypass had asymptomatic slow flow with a narrowed anastomosis, and another showed a severely stenosed STA correlating with later digital subtraction angiography. In the broader cohort, third (n = 5, median 1.2 years) and fourth (n = 1, 1.4 years) TCUS assessments demonstrated 100% patency. Among bypasses undergoing both TCUS and angiography (n = 31, 67.4%), findings were concordant in all cases. CONCLUSION/CONCLUSIONS:TCUS demonstrated complete agreement with formal angiography in assessing bypass patency, supporting TCUS as a reliable, noninvasive monitoring tool. Future research should explore quantitative TCUS flow measurements and their relationship to intraoperative flow and long-term graft remodeling.

BACKGROUND AND IMPORTANCE/BACKGROUND:Marfan syndrome's association with intracranial aneurysms, though controversial, poses unique challenges for surgical intervention because of the inherent vascular fragility. Open surgical approaches carry considerable risk. Endovascular flow diversion with the Pipeline embolization device (PED) offers a less invasive alternative, and adjunctive coiling can decrease occlusion time for complex aneurysms. We report the first combined use of PED and coiling to treat a Marfan-associated intracranial aneurysm, detailing our operative approach and reviewing the literature. CLINICAL PRESENTATION/METHODS:mutation was incidentally found to have an unruptured paraophthalmic aneurysm during stroke workup. Diagnostic angiography revealed an irregular superior hypophyseal aneurysm along with tortuous and irregular internal carotid arteries suggesting previous dissections. The aneurysm was successfully treated with a PED and adjunctive coil embolization. The patient was discharged on aspirin and clopidogrel. Six-month follow-up angiography confirmed aneurysm occlusion. Although there was no residual or recurrent aneurysm at 2-year follow-up, imaging revealed 2 de novo intracranial aneurysms. The patient remains asymptomatic and under observation. CONCLUSION/CONCLUSIONS:mutations and cerebrovascular pathology.

BACKGROUND:Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by fragile bones and vascular fragility, increasing the risk of vessel dissection and potentially complicating endovascular intervention. The authors present the first case of cranial bypass in a patient with OI. OBSERVATIONS/METHODS:A 38-year-old male with OI type I presented with a symptomatic left internal carotid artery (ICA) occlusive dissection managed with endovascular revascularization and stenting. Follow-up surveillance imaging identified an incidental right ICA dissection, also treated with stenting. Four years later, the patient experienced new right hemispheric symptoms. He was found to have progressive right ICA dissection on best medical management. Following an unsuccessful restenting attempt, he underwent a successful double-barrel superficial temporal artery-to-middle cerebral artery (STA-MCA) bypass to restore cerebral perfusion with no perioperative complications. Six-month follow-up DSA confirmed a patent bypass with robust flow, and the patient remained asymptomatic 1 year postoperatively. LESSONS/CONCLUSIONS:STA-MCA bypass can serve as a viable and effective revascularization option in patients with OI, whose disease predisposes them to vascular dissection. In these high-risk patients, cranial bypass is a safe method for effective flow augmentation to hypoperfused brain regions when endovascular interventions fail. https://thejns.org/doi/10.3171/CASE25378.

Definitive endoluminal reconstruction, widely known as flow diversion, revolutionized treatment of brain aneurysms. A range of targets, by location, size, etiology, and acuity, can be cured with an excellent risk/benefit profile. Requirement for effective antiplatelet state is balanced with superior treatment durability. Implant and delivery system technology continue to evolve. Some aneurysm types/locations remain undertreated. Maximizing efficacy while minimizing risks requires deep understanding of flow diversion principles, pathologic anatomy, endoluminal implants, delivery systems, and clinical management.

Although the concept of treating cerebral aneurysms by filling the sac from the inside (endosaccular) started many years ago first with detachable balloons and then coils, the use of a single metallic resheathable device acting as a flow disruptor is a much more recent innovation. The most studied device among these is certainly the WEB, which became part of standard clinical practice for treatment of wide-neck bifurcation aneurysms. This study reviews the most important features of the WEB device with a short summary of the most important literature. A small section at the end reviews also other endosaccular devices.

Imaging follow-up is an established component of intracranial aneurysm management that allows ongoing assessment of rupture risk and timely intervention to maintain protection from bleeding. Yet the frequency, duration, and imaging modality for follow-up vary widely. This review outlines contemporary imaging techniques and practice for follow-up of treated and untreated aneurysms, highlighting existing knowledge gaps and technical limitations that limit standardization. Updated evidence on the expected evolution and long-term outcome of common treatment strategies is presented to guide accurate reporting of radiological outcome after treatment and considerations regarding follow-up regimen.

IntroductionFlow diversion with the pipeline embolization device (PED) is an effective endovascular treatment. However, the metal surface's thrombogenicity and need for dual antiplatelet therapy (DAPT) are notable limitations. Few prior studies have reported specifically on flow diverters' safety in patients with hemoglobinopathies, a population at increased risk of thrombotic and hemorrhagic complications.MethodsNatural language processing queried our institution's medical records for intracranial embolization procedures from 2014 to 2024, screening for "hemoglobinopathy," "thalassemia," and "sickle cell." Patient charts were retrospectively reviewed.ResultsSixteen procedures in 14 patients were identified in which a mean 2.0 PEDs per patient were used. Most patients were female (71.4%). Median age was 48.8 years. Five patients had sickle cell disease, two had sickle cell trait, two had sickle cell or hemoglobin C trait and alpha thalassemia minor, and five had alpha thalassemia minor. The 14 patients were treated for 20 aneurysms; four treatments covered two distinct aneurysms. Median dome size per treatment was 4.0 mm. Of the 16 aneurysm treatments, five (31.2%) treated an irregular aneurysm. Most (56.2%) treatments used multiple PEDs. All patients were discharged on DAPT after verifying effect with P2Y12 assays. Follow-up DSA, CTA, or MRA was obtained in 12/14 (85.7%) patients at a median 1.6 years. Complete occlusion was achieved in all aneurysms. Clinical follow-up was obtained in all patients at a median 2.2 years. There were no thromboembolic or hemorrhagic complications, neurological deficits, or mortalities.ConclusionPipeline embolization can safely and effectively treat patients with hemoglobinopathies.

BACKGROUND:Older patients (≥80 years of age) were under-represented in randomized trials of endovascular thrombectomy (EVT). In the large Florida Stroke Registry (FSR), we aimed to evaluate the characteristics of the older patients receiving EVT in routine practice and to study the impact of age on EVT outcomes. METHODS AND RESULTS/RESULTS:Data prospectively collected from Get With The Guidelines-Stroke hospitals in the FSR from January 2010 to December 2022 were analyzed for EVT outcomes. Among patients receiving EVT, characteristics associated with age ≥80 years and the impact of age on EVT outcomes of discharge directly to home or acute inpatient rehabilitation, and independent ambulation at discharge were studied using multivariable analysis with generalized estimating equations. Among 20 004 EVT FSR patients (mean age 71±15, 50% women), 29% were ≥80 years of age. In multivariable analysis, older patients with EVT had a similar rate of symptomatic intracerebral hemorrhage and in hospital mortality but were less likely to achieve independent ambulation at discharge (odds ratio [OR]: 0.44 [95% CI, 0.39-0.49]), be discharged directly home (OR: 0.46 [95% CI, 0.42-0.51]) or to a rehabilitation facility (OR: 0.68 [95% CI, 0.61-0.75]). CONCLUSIONS:In routine practice, close to 30% of EVT treated stroke patients are over the age of 80 years. Our data shows that EVT is safe in this population; however, age remains an independent predictor of poor discharge outcomes post EVT.